FMR LLC
Holdings History for GeneDx Holdings Corp. - Class A common stock, par value $0.0001 per share (WGS)
- Symbol
- WGS on Nasdaq
- Latest disclosed shares
- 163,324 shares
- Security ownership percentage
- 0.6%
- Investment type
- Equity / Class A common stock, par value $0.0001 per share
Shares, Excluding Options vs Price
Value, Excluding Options
FMR LLC ownership in GeneDx Holdings Corp. Class A common stock, par value $0.0001 per share (WGS)
On 06 Aug 2025, FMR LLC filed SCHEDULE 13G/A with the Securities and Exchange Commission (SEC), disclosing ownership of 163,324 shares of GeneDx Holdings Corp. Class A common stock, par value $0.0001 per share (WGS).
This represents 0.6% ownership of the company.
Compared with the previous filing dated 12 May 2025, FMR LLC previously reported owning 2,793,953 shares, so the latest filing shows a decrease of 94%.
.
Schedule rows show beneficial ownership disclosures and amendments for this filer/security pair. Use the SEC filing link to verify source details.
| Reporting owner | Ownership | Ownership change | SEC-reported value | Shares | Share change | Share activity | Price | Form | Report date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|
| FMR LLC | 0.6% | -94% | $14,194,477 | 163,324 | -2,630,629 | -94% | $86.91 | 13G/A | 30 Jun 2025 | 06 Aug 2025, 12:01 |
| FMR LLC | 10% | $310,156,697 | 2,793,953 | $111.01 | 13G | 31 Mar 2025 | 12 May 2025, 10:32 |
13F rows show quarter-end holdings reported by the manager. Values are filing-reported market values; price checks are local estimates.
| Holdings as of | Option type | Portfolio weight | Value change | SEC-reported value | Shares | Share change | Share activity | Price | All holders |
|---|---|---|---|---|---|---|---|---|---|
| 30 Jun 2026 | 0% | -0% | $489,625 | 7,132 | -288,489 | -98% | $68.65 | Q2 2026 | |
| 31 Mar 2026 | 0% | -0% | $18,984,814 | 295,621 | -537,117 | -65% | $64.22 | Q1 2026 | |
| 31 Dec 2025 | 0.01% | +0% | $108,305,906 | 832,738 | +329,429 | +65% | $130.06 | Q4 2025 | |
| 30 Sep 2025 | 0% | +0% | $54,226,598 | 503,309 | +339,985 | +208% | $107.74 | Q3 2025 | |
| 30 Jun 2025 | 0% | -0.01% | $15,076,425 | 163,324 | -2,630,629 | -94% | $92.31 | Q2 2025 | |
| 31 Mar 2025 | 0.02% | +0.01% | $247,446,426 | 2,793,953 | +2,391,459 | +500% | $88.56 | Q1 2025 | |
| 31 Dec 2024 | 0% | +0% | $30,935,689 | 402,494 | +348,669 | +648% | $76.86 | Q4 2024 | |
| 30 Sep 2024 | 0% | +0% | $2,284,333 | 53,825 | +40,219 | +296% | $42.44 | Q3 2024 | |
| 30 Jun 2024 | 0% | 0% | $355,661 | 13,606 | -200 | -1.4% | $26.14 | Q2 2024 | |
| 31 Mar 2024 | 0% | 0% | $126,049 | 13,806 | -8 | -0.06% | $9.13 | Q1 2024 | |
| 31 Dec 2023 | 0% | +0% | $37,989 | 13,814 | +8,946 | +184% | $2.75 | Q4 2023 | |
| 30 Sep 2023 | 0% | +0% | $17,720 | 4,868 | +4,410 | +963% | $3.64 | Q3 2023 | |
| 30 Jun 2023 | 0% | 0% | $2,730 | 458 | +458 | NEW | $5.96 | Q2 2023 |
SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held.
* marks a reported price that did not pass the local price check.
* marks a reported price that did not pass the local price check.